Disclaimer: All stock information on i3capital.com is currently being fed from multiple sources and is updated automatically every 10-minutes. The information on this site is for information purposes only and i3 capital is neither responsible nor liable for the accuracy of this data.
Eshbal Engages the Howard Group for Investor Relations
VANCOUVER, BC, Sept. 16, 2025 /PRNewswire/ - Eshbal Functional Food Inc. (TSXV: ESBL) ("Eshbal" or the "Company"), a developer of scientifically-advanced gluten-free and health-focused food products, is pleased to announce that it has engaged The Howard Group Inc. ("The Howard Group") to provide strategic investor relations and capital markets communications services.
“Having reached record revenue milestones, and nearing operationalization of our expanded North American platform, we look forward to expanding awareness of our story together with the Howard Group" said Tomer Bar Meir, CEO of Eshbal.
The Howard Group's services will encompass a variety of investor-focused communications initiatives including targeted social media and other online awareness programs, together with a series of online and in-person interactive events.
"Eshbal has a very long and successful profitable history of creating, through proprietary processes and formulations, an extensive line of quality food products that have proven their appeal to people who either choose to or must follow a gluten free diet. There is a clear opportunity for Eshbal within this multi-billion-dollar segment of the population1" said Grant Howard, President of the Howard Group.
Pursuant to an agreement (the "Agreement") with The Howard Group dated September xx (the "Effective Date") Eshbal has engaged The Howard Group for an initial term of six months commencing on the Effective Date, and has agreed to pay The Howard Group $9,000 per month. The Howard Group will also be granted 250,000 options with an exercise price of $0.25, exercisable for a period of three-years from the grant date (the "Options"). The Options shall vest in four equal tranches, with 25% of the Options vesting every 3 months with the first such vesting to occur three months after the grant date.
Neither, The Howard Group, nor any of its shareholders or directors holds any interest, directly or indirectly, in Eshbal or it's securities and The Howard Group is an arm's-length party to Eshbal.
Eshbal Signs Additional Binding Agreement and Strengthens U.S. Leadership Team
VANCOUVER, BC, July 15, 2025 /PRNewswire/ - Eshbal Functional Food Inc. (TSXV: ESBL) ("Eshbal" or the "Company"), a developer of gluten-free and health-focused food products, is pleased to announce two strategic developments advancing its North American expansion:
The signing of a binding Letter of Intent to acquire a majority interest in the U.S.-based Dare to Be Different Foods company; and
The appointment of Avi Markus as Chief Commercial Officer (North America).
Eshbal Signs Binding Letter of Intent with Dare to Be Different
Eshbal announces that it has entered into a binding Letter of Intent (the "LOI"), with an effective date of July 3, 2025, to acquire a 55% interest (the "Interest") in the issued and outstanding securities, on a fully diluted basis (the "Acquisition"), of Dare to Be Different Foods ("D2BD"), a New York-based company specializing in low-carb, gluten-free, and natural-ingredient products made from broccoli and cauliflower. D2BD's product portfolio includes crusts, crisps, gnocchi, and related items, sold under its branded line through natural grocery chains and online platforms.
The consideration for the Acquisition shall consist of a combination of (i) a cash subscription by Eshbal for newly issued securities of D2BD, with the proceeds to be paid into the treasury of D2BD; and (ii) the issuance of shares in the capital of the Company ("Eshbal Shares") to the existing shareholders of D2BD. Together, these components represent the purchase price and will be payable upon closing of the Acquisition. Additionally, and provided that D2BD obtains certain revenue thresholds, additional Eshbal Shares may be issuable in the future. Closing of the Acquisition is subject to the parties entering into a definitive agreement, which will include customary closing conditions. The actual amount of cash payments and number of Eshbal Shares issuable shall be determined after completion of the due diligence process. The issuance price of Eshbal Shares will be determined on the date of execution and announcement of the definitive agreement. The Acquisition is subject to the approval of the TSX Venture Exchange.
The Acquisition is considered arm's length, and no finder's fees are payable.
Avi Markus Appointed Chief Commercial Officer for North America
Eshbal is pleased to announce the appointment of Avi Markus as its Chief Commercial Officer (CCO) for North America. Mr. Markus brings over 25 years of experience in consumer-packaged goods and "Better for You" food brands.
He previously served as SVP, North America – Retail at Else Nutrition and is a partner at The Matzo Project. Earlier in his career, he co-founded and launched emerging food brands including Nourishtea and BEON Energems, and held senior brand management and marketing roles at Unilever Canada and Shoppers Drug Mart. His expertise spans grocery, drug, mass, club, and foodservice channels, with a strong track record in e-commerce, DTC strategies, and omni-channel growth. Mr Markus also graduated with an MBA from Toronto's Schulich School of Business.
In his new role, Mr. Markus will lead commercial operations in North America, including sales, distribution, partnerships, and business development.
"I am so pleased to be joining this unique team of creative professionals in the field of Better-for-You nutrition," said Mr. Markus. "Eshbal is already a leading international player in healthier food solutions, and I look forward to introducing its products to leading retailers and foodservice accounts across the U.S. and Canada."
About Eshbal Functional Food
Eshbal Functional Food Inc. is a developer and manufacturer of health-focused food and nutraceutical products. With extensive experience in food innovation, the company leverages proprietary R&D and specialized production technologies to deliver Gluten-Free, Vegan, Low-Carb, Sugar-Free, and supplement-based solutions across a range of categories — from baked goods and spreads to protein blends, cereals, and dietary supplements.
Eshbal caters to a diverse mix of industrial, foodservice, and retail clients in Israel and abroad, and is now actively scaling its presence across the North American market. This expansion follows the successful completion of a reverse takeover (RTO) with Hakken Capital Corp., through which Eshbal became a publicly listed company on the TSX Venture Exchange as of April 14, 2025.
Eshbal is committed to making a meaningful impact on personal wellness — offering better choices for those seeking nutritious, innovative, and accessible food solutions. The Company's mission is to help people lead healthier lives by rethinking everyday food through science, purpose, and passion.
ESHBAL FOODS (TSXV:ESBL)
Eshbal Functional Food, Inc. engages in research, development, and manufacturing of food products and dietary supplements. Its products include: Sugar-Free, Vegan, Syrups, and Dry Mixes. The company was founded on October 11, 2018 and is headquartered in Vancouver, Canada.
Smart Nutrition for a Better Life.
Eshbal Functional Food is a leading and profitable food manufacturer specializing in gluten-free and “Better for You” products. With over 300 SKUs, including 80+ proprietary gluten-free items, we offer flours, baked goods, protein snacks, dietary supplements, and superfoods utilizing natural ingredients such as teff and chia. Our advanced food-technology enhances texture, flavor, and shelf life. We provide customized food development, catering to the gluten-free, vegan, sugar-free, and low-carb markets. Our expertise extends to sugar substitutes, sports nutrition, fortified powders, cereals, spreads, syrups, and more—ensuring high-quality formulations for optimal taste and nutrition.
Located in Kibbutz Ma’anit, Israel and supported by a team of 70 professionals, Eshbal operates a 60,000 sq. ft. facility with cutting-edge production lines and a dedicated food lab. The company is expanding into the North America (the largest gluten free market in the world) through merger and acquisition with food companies that have existing manufacturing and supply networks. Let’s innovate together—bringing healthier, high-quality food solutions to market.
